N,N,N-Trimethyl chitosan: An advanced polymer with myriad of opportunities in nanomedicine

被引:126
作者
Kulkarni, Abhijeet D. [1 ]
Patel, Harun M. [2 ]
Surana, Sanjay J. [3 ]
Vanjari, Yogesh H. [4 ]
Belgamwar, Veena S. [5 ]
Pardeshi, Chandrakantsing V. [1 ]
机构
[1] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut, Ind Pharm Lab, Shirpur, Maharashtra, India
[2] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Div Comp Aided Drug Design, Shirpur, Maharashtra, India
[3] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmacognosy, Shirpur, Maharashtra, India
[4] NIPER, Dept Pharmaceut Chem, Med Chem Lab, Hyderabad, Karnataka, India
[5] RTM Nagpur Univ, Dept Pharmaceut Sci, Nagpur, Maharashtra, India
关键词
Chitosan; Trimethyl chitosan; Mucoadhesion; Nanomedicine; Tissue engineering; Nasal vaccine; N-TRIMETHYL CHITOSAN; PENETRATION ENHANCEMENT PROPERTIES; CACO-2 CELL MONOLAYERS; EXCISED RAT JEJUNUM; IN-VITRO EVALUATION; TNF-ALPHA SIRNA; ORAL DELIVERY; MOLECULAR-WEIGHT; NASAL VACCINATION; TMC NANOPARTICLES;
D O I
10.1016/j.carbpol.2016.10.041
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
N,N,N-trimethyl chitosan (TMC), a quaternized hydrophilic derivative of chitosan (CHT), outperformed the well-known solubility issues raised by CHT. The excellent properties offered by TMC provide it a significant edge for nanoparticle (NP) formation over other nanocarrier materials. Recently, TMC NPs have been applied to various fields like pharmaceutical, biomedical, biomaterials, and biotechnological field. The aim of this review is, therefore, to bring the TMC into the limelight so as to appraise it as an attractive functional polymer for nanomedicine applications which is facing oversight, at present, by regulatory agencies and manufacturers. The versatility of surface-tailoring, the capability of further chemical modifications, and the feasibility of ligand-conjugations in TMC polymer will further assist the scientists for reaching new dimensions in the nano-assembly of novel structures based on TMC. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:875 / 902
页数:28
相关论文
共 156 条
[1]   Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system [J].
Amidi, M ;
Romeijn, SG ;
Borchard, G ;
Junginger, HE ;
Hennink, WE ;
Jiskoot, W .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :107-116
[2]   N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model [J].
Amidi, Maryam ;
Romeijn, Stefan G. ;
Verhoef, J. Coos ;
Junginger, Hans E. ;
Bungener, Laura ;
Huckriede, Anke ;
Crommelin, Daan J. A. ;
Jiskoot, Wim .
VACCINE, 2007, 25 (01) :144-153
[3]  
[Anonymous], FOOD HYDROCOLL, DOI DOI 10.1016/J.F00DHYD.2011.09.002
[4]  
[Anonymous], 2014, J NANOMED NANOTECHNO, DOI DOI 10.4172/2157-7439.1000240
[5]   Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use [J].
Asasutjarit, Rathapon ;
Theerachayanan, Thitaree ;
Kewsuwan, Prartana ;
Veeranodha, Sukitaya ;
Fuongfuchat, Asira ;
Ritthidej, Garnpimol C. .
AAPS PHARMSCITECH, 2015, 16 (05) :1013-1024
[6]   Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice [J].
Bal, Suzanne M. ;
Slutter, Bram ;
Verheul, Rolf ;
Bouwstra, Joke A. ;
Jiskoot, Wim .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 45 (04) :475-481
[7]   Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation [J].
Bal, Suzanne M. ;
Slutter, Bram ;
Jiskoot, Wim ;
Bouwstra, Joke A. .
VACCINE, 2011, 29 (23) :4025-4032
[8]   Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations [J].
Bal, Suzanne M. ;
Slutter, Bram ;
van Riet, Elly ;
Kruithof, Annelieke C. ;
Ding, Zhi ;
Kersten, Gideon F. A. ;
Jiskoot, Wim ;
Bouwstra, Joke A. .
JOURNAL OF CONTROLLED RELEASE, 2010, 142 (03) :374-383
[9]   The safety of chitosan as a pharmaceutical excipient [J].
Baldrick, Paul .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 56 (03) :290-299
[10]   Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform [J].
Baudner, BC ;
Verhoef, JC ;
Giuliani, MM ;
Peppoloni, S ;
Rappuoli, R ;
Del Giudice, G ;
Junginger, HE .
JOURNAL OF DRUG TARGETING, 2005, 13 (8-9) :489-498